TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmapress Oy
Closing information (x1000 EUR)
Closing information | 2017/12 | 2016/12 | 2015/12 |
Turnover | 1,100 | 1,223 | 1,379 |
Financial expenses | 0 | ||
Earnings before taxes | 68 | 52 | 69 |
Total assets | 651 | 637 | 641 |
Current assets | 369 | 515 | 496 |
Current liabilities | 123 | 113 | 107 |
Equity capital | 527 | 524 | 533 |
- share capital | 30 | 30 | 30 |
Financial ratios
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Solvency | 81.0% | 82.3% | 83.2% |
Turnover per employee | |||
Profit as a percentage of turnover | 6.2% | 4.3% | 5.0% |
Return on assets (ROA) | 10.8% | ||
Current ratio | 300% | 455.8% | 463.6% |
Return on equity (ROE) | 12.9% | 9.9% | 12.9% |
Change turnover | -123 | -156 | -107 |
Change turnover % | -10% | -11% | -7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.